Search research articles
Contact Us
Filters
Showing results (1-10 of 15) with videos related to
Page
of 2
Sort By:
Molecular Biology of the Cell
|
June 20, 2008
Latrunculin A delays anaphase onset in fission yeast by disrupting an Ase1-independent pathway controlling mitotic spindle stability
John C Meadows, Jonathan Millar
Therapeutic Advances in Respiratory Disease
|
March 28, 2014
The use of high-flow nasal oxygen therapy in the management of hypercarbic respiratory failure
Jonathan Millar, Stuart Lutton, Philip O'Connor
Expert Review of Respiratory Medicine
|
November 11, 2020
Mesenchymal stromal cells for acute respiratory distress syndrome (ARDS), sepsis, and COVID-19 infection: optimizing the therapeutic potential
Ellen Gorman, Jonathan Millar, Danny McAuley, et al.
Journal of Diabetes
|
May 28, 2016
The soda dipstick: A convenient and cost-effective means of identifying the sugar content of soft drinks
Jonathan Devaney, Ryan Smyth, Stuart Lutton, et al.
Pilot and Feasibility Studies
|
March 2, 2019
A study protocol for a feasibility study: Propofol Target-Controlled Infusion in Emergency Department Sedation (ProTEDS)-a multi-centre feasibility study protocol
Fiona M Burton, David J Lowe, Jonathan Millar, et al.
Critical Care (London, England)
|
July 18, 2014
Extracorporeal carbon dioxide removal for patients with acute respiratory failure secondary to the acute respiratory distress syndrome: a systematic review
Marianne Fitzgerald, Jonathan Millar, Bronagh Blackwood, et al.
Emergency Medicine Journal : EMJ
|
December 10, 2020
Propofol Target-Controlled Infusion in Emergency Department Sedation (ProTEDS): a multicentre, single-arm feasibility study
Fiona Marie Burton, David John Lowe, Jonathan Millar, et al.
Frontiers in Medicine
|
July 22, 2022
Validation of Messenger Ribonucleic Acid Markers Differentiating Among Human Acute Respiratory Distress Syndrome Subgroups in an Ovine Model of Acute Respiratory Distress Syndrome Phenotypes
Karin Wildi, Kieran Hyslop, Jonathan Millar, et al.
Vaccines
|
September 28, 2024
Changes in Phenotypic and Molecular Features of Naïve and Central Memory T Helper Cell Subsets following SARS-CoV-2 Vaccination
Mia Mosavie, Jennifer Rynne, Matthew Fish, et al.
BMJ Open
|
December 3, 2020
Design and rationale of the COVID-19 Critical Care Consortium international, multicentre, observational study
Gianluigi Li Bassi, Jacky Suen, Adrian Gerard Barnett, et al.
Page
of 2
Search research articles
Search
Showing results (1-10 of 15) with videos related to
Sort By:
Page
of 2
Molecular Biology of the Cell
|
June 20, 2008
Latrunculin A delays anaphase onset in fission yeast by disrupting an Ase1-independent pathway controlling mitotic spindle stability
John C Meadows, Jonathan Millar
Therapeutic Advances in Respiratory Disease
|
March 28, 2014
The use of high-flow nasal oxygen therapy in the management of hypercarbic respiratory failure
Jonathan Millar, Stuart Lutton, Philip O'Connor
Expert Review of Respiratory Medicine
|
November 11, 2020
Mesenchymal stromal cells for acute respiratory distress syndrome (ARDS), sepsis, and COVID-19 infection: optimizing the therapeutic potential
Ellen Gorman, Jonathan Millar, Danny McAuley, et al.
Journal of Diabetes
|
May 28, 2016
The soda dipstick: A convenient and cost-effective means of identifying the sugar content of soft drinks
Jonathan Devaney, Ryan Smyth, Stuart Lutton, et al.
Pilot and Feasibility Studies
|
March 2, 2019
A study protocol for a feasibility study: Propofol Target-Controlled Infusion in Emergency Department Sedation (ProTEDS)-a multi-centre feasibility study protocol
Fiona M Burton, David J Lowe, Jonathan Millar, et al.
Critical Care (London, England)
|
July 18, 2014
Extracorporeal carbon dioxide removal for patients with acute respiratory failure secondary to the acute respiratory distress syndrome: a systematic review
Marianne Fitzgerald, Jonathan Millar, Bronagh Blackwood, et al.
Emergency Medicine Journal : EMJ
|
December 10, 2020
Propofol Target-Controlled Infusion in Emergency Department Sedation (ProTEDS): a multicentre, single-arm feasibility study
Fiona Marie Burton, David John Lowe, Jonathan Millar, et al.
Frontiers in Medicine
|
July 22, 2022
Validation of Messenger Ribonucleic Acid Markers Differentiating Among Human Acute Respiratory Distress Syndrome Subgroups in an Ovine Model of Acute Respiratory Distress Syndrome Phenotypes
Karin Wildi, Kieran Hyslop, Jonathan Millar, et al.
Vaccines
|
September 28, 2024
Changes in Phenotypic and Molecular Features of Naïve and Central Memory T Helper Cell Subsets following SARS-CoV-2 Vaccination
Mia Mosavie, Jennifer Rynne, Matthew Fish, et al.
BMJ Open
|
December 3, 2020
Design and rationale of the COVID-19 Critical Care Consortium international, multicentre, observational study
Gianluigi Li Bassi, Jacky Suen, Adrian Gerard Barnett, et al.
Page
of 2